◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksL › LCTX

Lineage Cell Therapeutics, Inc. (LCTX) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-08-22

Lineage Cell Therapeutics, Inc. (LCTX) operates in the Biotechnology industry and is headquartered in Carlsbad, United States with about 72 employees. Its market capitalization is roughly ₪823 million. In the fiscal year ended 2025-12-31, LCTX reported $15M in revenue and ($64M) in net income.

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical conditions in the United States and internationally.

Interactive charts & full statements →

LCTX Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$15M$10M$9M$15M
Gross Profit$14M$9M$8M$14M
Operating Income (EBIT)($22M)($22M)($25M)($22M)
Net Income($64M)($19M)($22M)($26M)

ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.

LCTX Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$1M$2M$7M$4M$3M
Gross Profit$1M$2M$6M$4M$3M
Operating Income (EBIT)($9M)($8M)($6M)($4M)($5M)
Net Income$2M($5M)$1M($30M)($30M)

ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.

LCTX Free Cash Flow History

LCTX Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$113M$113M$101M$124M
Total Liabilities$69M$36M$39M$52M

ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LCTX viewer.

Other Companies in Biotechnology

This page in other languages: עברית

← LCTUAll “L” companiesLCUT →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.